Crack Baby Theory Debunked
Infants and toddlers whose mothers used cocaine during pregnancy don't seem to have brain abnormalities or developmental
problems attributable to the drug, according to a new analysis of research done over the last decade.
The study disputes the stereotype of the "crack baby" -- a pathetic, permanently damaged person unlikely to live a normal
life. It does not, however, absolve cocaine of any damaging effect during pregnancy, or declare the drug safe for expectant
mothers.
"There is no need to assume that [cocaine-exposed babies] are a doomed generation or a biologic underclass, which is what
was said about them initially," said Deborah A. Frank, a pediatrician at the Boston University School of Public Health. "The
idea that these children are uniquely 'unteachable' or somehow out of control is simply not supported by the data."
Writing in today's Journal of the American Medical Association, the researchers concluded that many developmental
abnormalities attributed to cocaine exposure "can be explained in whole or in part by other factors, including prenatal exposure to tobacco, marijuana, or
alcohol, and the quality of the child's environment."
The conclusions are valid only for children up to age 6 because longer-range evaluations are not finished. The National
Institute on Drug Abuse, a branch of the National Institutes of Health, is following 14 groups of cocaine-exposed children.
"There are some subtle developmental outcomes that many laboratories are beginning to see as children get close to
adolescence," said Alan I. Leshner, director of NIDA. "We need to be careful not to fall prey to a false sense of security."
Frank and her colleagues looked at 36 studies in which drug tests were given to women during pregnancy, or to their babies
at birth. The children's development was then followed over time.
Many of the women used numerous drugs, including legal ones such as tobacco and alcohol, and many had other risk
factors for delivering unhealthy babies, including poor diet, lack of prenatal care and poverty.
With so many variables at work, discerning cocaine's contribution to bad outcomes has been difficult. Most of the 36 studies
-- all published previously -- tried to do that. What the researchers did was look at them together to determine a trend.
As a generality, the studies found that when a woman used alcohol and tobacco, or alcohol and marijuana, cocaine use had
little or no "incremental impact" on her child's risk of problems after birth.
Specifically, cocaine had no lasting effect on physical growth; it generally did not affect the cognitive ability of infants or
young children; it did not affect language skills (although few studies looked at this question); and a deleterious effect on
motor skills that some researchers had found seemed not to extend beyond the first six months of life.
The most difficult area to assess was cocaine's possible effects on social behavior, mood and attention. Several studies found that cocaine-exposed children showed less joy, sadness or interest in learning tasks. Overall,
though, children of cocaine-using mothers have no clear-cut behavioral problems.
Only some of the studies compared women who used cocaine (and other drugs) with women who used no drugs.
Consequently, it's not possible to conclude that cocaine confers no risk -- only that its effects are similar, and not more
severe, than other known risks to infants.
Previous research has shown that cocaine use raises the chances that a baby will be born prematurely, or will have a low
birthweight, twofold to fourfold. Preterm birth and low birthweight also are risks for developmental problems.
In recent years, prosecutors in many states have tried to detain, forcibly treat or punish pregnant women found to be taking
illegal drugs. In most cases, the women were compulsive users of crack cocaine.
In 22 states where the charges were challenged, courts have ruled in favor of the women. Last week the Supreme Court ruled that a South Carolina hospital overstepped its bounds in 1989 when
it tested the urine of pregnant women for drugs and forwarded the results to police. Thirty women were arrested under that
program, which was abandoned in 1994.
David S. Cohen, a lawyer with the Women's Law Project in Philadelphia, said most attempts to treat drug use during
pregnancy as a crime occurred in the early 1990s "in direct response to the original hype of the so-called 'crack baby.' "
While such actions are rare today, "we still occasionally hear of prosecutions of pregnant women around the country," he said.
To view the entire article, go to http://www.washingtonpost.com/wp-dyn/articles/A1700-2001Mar27.html
Ecstasy Panic Looms: 1985 All Over Again?
In signs of an impending moral panic, in the last three
weeks, media outlets across the U.S. and Canada have
published a spate of Ecstasy (MDMA) scare stories, with a
major Time magazine article hitting the newsstands this
coming week. The stories, clustered in the San Francisco Bay
area, Western Canada, the U.S. Midwest, Toronto and Florida,
tend to follow a similar pattern: young person dies after
ingesting Ecstasy (or often another drug sold as Ecstasy);
drug fighters raise hue and cry; reporter describes exotic
rave scenes; police issue ominous warnings of impending doom.
This flurry of interest bears a remarkable resemblance to
previous drug panics, including the Ecstasy panic of 1985,
when the drug emerged in Texas nightclubs and was being
touted in press reports as the "yuppie drug." Headlines like
"Madness, Not Ecstasy" and "The Agony of Ecstasy" (which has
lamentably been reached for again by more than one uninspired
headline writer) prodded the DEA to undertake an emergency
reclassification of the drug to the prohibitive Schedule I,
severely increasing criminal penalties for its use and
distribution.
Now, fifteen years later, the Ecstasy menace again threatens
the nation. Or does it? In the University of Michigan's
annual surveys, high school seniors report a slight upward
trend in experimental use, from 5.8% in 1997 to 8% in 1998.
Still, the number using Ecstasy on a monthly basis is so low
-- less than one percent -- that the drug doesn't even
register on the federal drug use survey.
Still, based on a handful of reported deaths and an increase
in the amount of the drug seized by Customs authorities,
federal officials began hyping the threat. Last November,
NIDA began a web site,
In Florida, the state's new drug czar (an alumnus of the
National Office on Drug Control Policy) has been caught
exaggerating the threat from Ecstasy and other "club drugs."
After last summer's Operation Heat Rave, a statewide raid on
the clubs, Florida state drug experts decided they needed
proof of the deadly epidemic. They claimed to have found a
total of 254 club drug deaths, but the Orlando Sentinel
ripped those findings to shreds (previous WOL coverage at
http://www.drcnet.org/wol/138.html#floridacount).
The Florida paper found that the drug fighters had included
every death that tested positive for a list of some 20 drugs,
some widely used in the rave scene, some occasionally used,
and some not even linked to that scene. Even worse, the
numbers included such hard-partying teens as the 58-year-old
man who died after a heart bypass, an infant crib death,
middle-aged methamphetamine users and terminal cancer
patients.
Now, with more than half of the "club drug" deaths being
rightfully attributed to other causes, the Florida drug
czar's credibility is severely damaged, and even NIDA is
concerned. "Questionable data on the nature of the problem
will tend to put all data in question... There's a tendency
not to believe any of that government drug data," a NIDA
researcher told the Sentinel.
Observers less excitable than those Florida officials
recognize that MDMA is a relatively safe drug with a low
death rate, although its use does carry with it serious
health concerns. In the short term, the greatest danger (and
the cause of most Ecstasy-related deaths) is "overheating,"
caused by the drug's effects on the body's ability to
regulate body temperature. According to Rick Doblin of the
Multidisciplinary Association for Psychedelic Studies
(http://www.maps.org), overheating deaths represent a tiny
minority of Ecstasy users, and the best available numbers
back him up. The national medical emergency room survey,
DAWN, reports a total of 27 deaths from 1994 through 1998.
And, Doblin notes, simple harm reduction measures (drink lots
of fluids, move to cool or air conditioned areas) can
virtually eliminate that threat.
The primary long-term health concern with MDMA remains its
impact on serotonin production and changes in brain
structures. The research in this area is not conclusive, but
some scientists warn of possible memory loss or premature
aging as a result of repeated use. Again, Doblin demurs,
pointing out that these possible effects are "clinically
insignificant," meaning that no research done thus far has
found statistically conclusive evidence of quantifiable
behavioral change.
Some of the recent deaths that have fueled press attention
are in fact not from Ecstasy but from substitutes sold to
unsuspecting consumers as Ecstasy. Two Chicago area youths
who thought they were taking Ecstasy died when the pills they
ingested turned out to be PMA (paramethoxyamphetamine), a
more dangerous substance. Still, this fact did not stop the
Chicago area press from parroting alarmist information from
local police and prosecutors. As area police went on the
alert for Ecstasy, however, other area papers were forced to
admit "Ecstasy Drug Not Yet an Epidemic in the Region,"
(Munster Times). One suburban Chicago policeman was quoted
as saying "no arrests" had been made in his district; another
worried, "I don't know how bad it is now. I want to focus on
how bad it is."
It is worth noting that much of the risk associated with
Ecstasy derives from adulterants or substitutes, as was the
case in Chicago. DanceSafe (http://www.dancesafe.org), an
Oakland-based Ecstasy harm reduction organization, has
reported that 20% of the tablets tested at local raves were
not Ecstasy, with that figure rising to 40% for samples sent
to its offices from elsewhere in the country. In the
forthcoming Time article, the writers describe an Oakland
rave where nine people required hospitalization; DanceSafe
confirmed that all but one had actually taken something other
than Ecstasy.
None of this has prevented law enforcement and elected
officials at all levels from pursuing efforts to heighten
penalties for MDMA use and possession. Senators Charles
Grassley (R-IA) and Bob Graham (D-FL) recently introduced the
Ecstasy Antiproliferation Bill, which would dramatically
decrease the amount of the drug sold needed to trigger
serious trafficking charges. In Illinois, the Chicago
Tribune reports, a move is afoot to elevate Ecstasy sales
from a Class 3 to a Class X felony, which imposes a mandatory
minimum sentence of at least six years. Class 3 felony
sentences, on the other hand, range from probation to a
maximum of two years.
And the drug itself is not the only target. Officials in
Chicago, Toronto and Vancouver, among other places, are using
the Ecstasy scare to attack raves, the popular all-night
dance parties around which a young counterculture is
centered. In Chicago, the City Council quietly passed an
ordinance to inhibit raves. After the death of a 20-year-old
at a Toronto rave last October, authorities there are
considering a variety of measures to restrict or ban the
parties.
The combination of a vibrant youth counterculture -- the rave
scene -- and a pleasure-enhancing drug such as Ecstasy is a
fertile breeding ground for a full-blown moral panic. The
forthcoming article in Time is reasonably balanced (although
visit http://www.maps.org/research/mdma/time.html for some
criticisms), but other media, law enforcement and elected
officials have their own motivations for exaggerating or
sensationalizing the issue. If the past is any indication,
we may well be in for the Summer of Ecstasy, and such
frenzies usually result in a new round of harsh criminal
penalties for the substance in question. And why not? After
all, Ecstasy is "no different from crack, heroin," according
to an Orlando detective quoted on 60 Minutes II in April.
Commentary on the MDMA panic
Yup, looks like Ecstasy is going to be the Great Satan of the Month
Again. The article is pretty factual. Main physical dangers from E., like
most psychedelics, are overheating or heart irregularities, but occur only
if too much is taken or if the person is in an overheated, poorly
ventilated space, or has a pre-existing heart condition. Overdoses are
mainly an artifact of prohibition - - you can never be sure of the dose
from the stuff you score on the street. Even being in an overheated area
probably isn't risky to one's health unless you combine a heavy dose with
something like alcohol. A good remedy in cases like that is just a wet
cloth on the forehead. Actually, I know of a "certain person" who has used
psychedelics under 100+ degree temperatures with no problems.
If one does have a heart condition, one can overcome the problem of
rapid heartbeat by taking a beta-blocker such as propanolol (this works
with cocaine and amphetamine, also).
The "problem" of changes in neural structure is also controversial
- - they only seem to show up with heavy use, and there hasn't been any
demonstration that they are actually damaging. It may even be that
moderate use of E. or psychedelics promotes neuronal interbranching and
increased blood flow to the brain, which may mean that use actually may
enhance intelligence - - see the research done by Dr. Charles Grob at
Harbor-UCLA Hospital.
The Straight Dope on Rohypnol
Well, it looks like the evil geniusses at Hofmann-La Roche who try
to unleash drug menaces on the American People have been foiled again.
Igor and company working down in the dungeon laboratory came up with a
horrifying drug called Rohypnol which was a threat to the well being of
every American and the virtue of the female side of the population.
Fortunately, our wise shepherd-guardians in the government were on the ball
and exposed and crushed the evil plot (or so the public has been led to
believe.). Congress hurried through a bill to criminalize the possession
of Rohypnol and to outlaw its use to knock somebody out in the commission
of a felony with only one dissenting vote. (More on that later.)
President Clinton rushed to sign it. Truly, Rohypnol is the latest Great
Satan of the War on Drugs.
Actually, Rohypnol TM is quite a useful drug. Known more technically as
flunitrazepam, it is a close cousin to diazepam, or Valium TM, also a
Hofmann-La Roche product. It is sold in over 65 countries and is used for
much the same purposes as Valium TM: as a minor tranquilizer, a muscle
relaxant and antispasmodic, as a pretreatment for surgery (it lowers blood
pressure, thus reducing bleeding during surgery), and as a sleep aid. It
is several times as potent as diazepam (potency is always a bad thing in
Drug War Theology, witness the scares over high potency marijuana and
manipulated nicotine levels in cigarettes.) Since its toxicity is not
proportionately increased, this means that its index of safety, or the
toxic dose divided by the therapeutic dose is much greater than diazepam,
which is in turn much greater than drugs like the barbiturates.
One of the unfortunate effects of the hypnotics, which include
Rohypnol, Valium, the barbiturates, chloral hydrate, and others, is that
they combine synergistically with alcohol to multiply their effects, which
can catch a naive user unaware. The Mickey Finn, a stock item of detective
fiction for the last hundred years, was chloral hydrate slipped into a
persons alcoholic drink. Some individuals have deliberately combined
hypnotics and alcohol as part of their drug use, notably the poet/painter
Dante Gabriel Rossetti, who combined chloral hydrate and alcohol, and the
actor Bela Lugosi, who combined alcohol and paraldehyde (NOT formaldehyde,
it and paraldehyde are two completely different chemicals.) The combined
effects of hypnotics and alcohol produce enhanced intoxication in small
doses and with larger doses can cause loss of consciousness with a degree
of amnesia. (Lugosi and Rossetti probably used the amnesiac effects to
hide the pain of their personal lives.) In even larger doses it can
depress the central nervous system enough to cause death. Actresses Mary
Ure and Billie Carleton inadvertently killed themselves in this way. The
famous case of Karen Ann Quinlan was a similar happenstance.
So Rohypnol is a safer form of Valium which is safer than
barbiturates--so why was it outlawed? Unavailable in this country because
of the usual FDA footdragging with approving new drugs, it was used in a
few sensational cases of date rape. (As I mentioned, any of the other
hypnotics could have been used as well.) The Rohypnol scare has the classic
pathology of a drug scare: The triangle of several lurid and hysterical
stories in the press, alarmist warnings from law enforcement, and
grandstanding by politicians to show they are tough on drugs. Politicians
as diverse as Tom Hayden, Orrin Hatch, Dianne Feinstein, and my favorite
nutzo drug warrior, New York Republican Congressman Gerald Solomon, all
jumped on the Rohypnol bandwagon. Solomon, fresh from trashing the Tenth
Amendment with his bill mandating 48 hour insurance coverage for maternity,
delivered an uppercut to the Tenth with another bill outlawing the use of a
drug in the commitment of a felony. For the first time, and with no
constitutional authority, slipping someone a Mickey Finn is now a federal
offense, along with such other newly created federal offenses as scrawling
graffiti on the side of a church. ("Make a federal offense out of it,"
meaning to react all out of proportion to a situation, is a phrase you never
hear anymore: today, everything is a federal offense. Come to think of it,
you never hear the phrase "it's a free country," anymore, either.) There is now
a three year federal sentence for mere possession of Rohypnol and a twenty
year sentence for its use in a felony. The extreme punishment for its use
has the interesting effect of proportionately lowering the penalty for use
of a firearm or other deadly weapon in a felony instead.
The swift passage of the anti-Rohypnol bill is another illustration
that the problem with government is not, as the populists would have it,
that government is unresponsive. It is hyper-responsive. The problem with
government is not that it lacks reflexes, it lacks brains. Where were the
expert witnesses? Where was the cool deliberation? Where was the
Constitution? Nowhere to be seen. To the extent that this safer drug is
for all intents and purposes condemned in perpetuity, and to the extent
that more hazardous drugs will be used instead, with a certain number of
inevitable deaths, Congress, Clinton, and the FDA will be indirectly
responsible for several hundred deaths each year, at least.
As I mentioned, one and only one Representative voted against the
Rohypnol bill, and for this I present her, with a certain sense of irony,
the Defender of the Constitution Award. That Representative is L.A.
Democrat Maxine Waters, who denounced the bill as a cynical election year
ploy. Of two major attacks on the Tenth Amendment this year, namely the
Medical Insurance Reform bill and the Rohypnol bill, the only person in
either party to vote against either one was none other than Ms. Waters.
Not that I claim that Ms. Waters is a principled constitutionalist, any
more than anyone else of either party in Washington, but these days one has
to take respect for the Constitution anywhere one can find it.
JUST SAY YES!
"The breakfast table may someday feature not only orange
juice and vitamins but also a more exotic health booster - - a compound
extracted from marijuana."
"Cannabis contains a chemical that can protect cells by
acting as an antioxidant, a new study shows. More effective than vitamins
C or E, it offers an appealing option for the treatment and perhaps
prevention of stroke, neurodegenerative diseases, and heart attacks, the
researchers suggest."
--Science News, Vol. 154 (July 11, 1998)
The report in Science News is a digest of a report in July
7 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES. The researchers found
that cannabadiol (CBD), a component of marijuana, does a great job of
quenching the free radical toxins typically released in strokes; in fact,
it's a great fat-soluble type antioxidant overall. The researchers hasten
to add that CBD isn't the stuff in cannabis that makes you feel good
(actually, it has something of a reputation as being the stuff in ditch
weed that gives you that yecchy feeling, though I know of no studies that
actually confirm this.) Interestingly, tetrahydrocannabinol (THC, the
stuff in grass that makes you feel good) is just as effective as CBD,
according to the researchers. (But God forbid anything good for you should
actually make you feel good!) CBD and THC are actually chemical isomers -
- they have the same number and type of atoms but differ slightly in their
structure - - like lactose (milk sugar) and sucrose (cane sugar).
What this suggests is that habitual users of cannabis should suffer fewer strokes,
Alzheimer's and Parkinson's cases, and heart disease than non-users.
Sounds like we need some long term studies on the manner.
As you well know, Selegiline, a.k.a. L-Deprenyl, a.k.a.
Eldepryl, a.k.a. Selepryl, has wonderful qualities as a cognitive enhancer.
It has also shown positive results in rats as a life extension drug and
also preserving sexual function in aged specimens. Alas, it's available
only by prescription at high prices. To counter this, many Americans have
been traveling to Mexico to procure supplies. Naturally, the U.S.
government doesn't like this. (What could be more scary to a government
than a bunch of smart, horny people?) Consequently, the Feds have been
cracking down on individual imports of Selegiline, although it's supposed
to be legal.
Lo and behold, a new source of supply may be in the offing.
According to the Oct. 17, 1998 edition of Science News, Selegiline may
soon be prescribed for aging pets to counter loss of cognitive functioning.
There is actually an organization called Deprenyl Animal Health in
Overland Park, Kansas. (William W. Ruehl, vice president of scientific
affairs.) They have applied to the FDA to market Selegiline for aged
animals. It's already been approved in Canada under the name Anipryl.
(It's approved in the U.S. for a condition called Canine Cushing's Disease,
a hormonal imbalance.) Deprenyl Animal Health also wants to test it for
use in cats, but it's harder to detect loss of cognitive function in cats.
Although I'm absolutely sure nobody I know would ever do this, I wonder if
some pet owners might be tempted to dip into Bowser's stash.
**********************************
While we're on the subject of drugs for animals, the London Zoo is
investigating the use of Viagra for animals. Certain species such as the
black rhino and the saharan oryx, show no interest in mating while in
captivity. Zoo officials hope that Viagra will induce them to mate.
They're also interested in its use to increase mating behavior in species
such as the panda and tiger. Horse and dog breeders are also interested in
its use in extending the stud life of champion males.
************************************
Back to humans, the Nov. 9 [Los Angeles] Daily News carried a story on the
cognitive enhancing effects of nicotine. Seems it definitely improves
memory, and might be tried in Alzheimer's patients. Since nicotine is
politically incorrect, researcher might try some derivitive of nicotine
rather than nicotine itself.
The researchers were also quick to decry smoking despite its beneficial
effects. (For some reason, the L.A. Times didn't carry this story - - I'm
also reminded how officials were quick to caution against drinking when
research showed the beneficial effects of moderate alcohol use.)
INDEX
from the DRCN
by Robert G. Weber, Jr.